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Osteopetrosis  is  a  disease  of bone  resorption  that  may  be  inherited  with  many 
separate genes in various mammalian species (1, 2). There are four distinct mutations 
in  the  mouse  that  can  individually  result  in  this  disorder:  osteopetrotic  (op)  (3), 
microopthalmic  (mi)  (4),  gray-lethal  (gl)  (5),  and  osteosclerotic  (oc)  (6).  A  major 
advance  in  our  understanding  of osteopetrosis was  provided by the  experiments  of 
Walker  (7-9),  demonstrating  the  ability of normal  hemopoietic  cells  to  cure  this 
disorder in  mi/mi  and gl/gl  mice.  Additionally, it was  shown  that  spleen  cells from 
these mutants  transfer the disease into irradiated normal  littermate recipients (8, 9). 
The response of other murine osteopetrotic mutants in transplantation assays remains 
unknown.  At  the  cellular level,  osteopetrosis  is  a  disease of a  functionally  and/or 
quantitatively abnormal osteoclast  (1,  10),  The osteoclast is a  multinuclear cell that 
is most probably formed through a fusion of cells of the monocyte-macrophage lineage 
(11).  Therefore,  the  osteoclast  belongs  to  the  progeny  of the  hemopoietic stem  cell 
(HSC) 1 (12,  13),  and  this  explains the  positive response  of mi/mi  and gl/gl  mice  to 
transplants of hemopoietic cells. This cure of osteopetrosis by hemopoietic grafts is a 
more general phenomenon  and was recently observed also in juvenile osteopetrosis in 
man  (14,  15)  and  in two rat mutants:  ia/ia  (16)  and op/op  (17).  Studies (18)  in op rat 
additionally linked osteopetrosis with abnormalities in the T  lymphocyte system. On 
the  other  hand,  the  osteopetrosis in  tl/tl  rat  failed to  respond  to  the  bone  marrow 
transplant  (19),  suggesting that  the primary lesion in  this mutant  resides beside the 
hemopoietic  tissue,  presumably  in  the  hemopoietic  microenvironment  (HM).  The 
HM  is made by stromal tissue of bones and spleen, histogenetically different from the 
hemopoietic system  and  largely derived  from  cells with  fibroblast-like morphology 
(20).  The  classic example of the  disorder of HM  is anemia  in  S1/S1  d mice,  which  is 
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neither  cured  with  transplants  of  normal  hemopoietic  cells  nor  transferred  with 
hemopoietic cells of defective animals (21, 22). The potent interrelationship between 
osteopetrosis, the hemopoietic System, and HM prompted us to define the hematolog- 
ical competence of one of the osteopetrotic mutants, the op/op mouse. Furthermore, 
cells of monocyte-macrophage lineage, to which the osteoclast belongs, and fibroblas- 
told  cells that  compose  the  HM  were  analyzed during their  in vitro growth.  The 
results of these investigations constitute the present report. 
Materials and Methods 
Animals.  Male C57BL/6J mice were obtained from The Jackson Laboratory (Bar Harbor, 
ME) and were used between 3 and 6 wk of age. Osteopetrotic mice and breeding pairs for these 
mice were  also obtained from The Jackson Laboratory. The osteopetrotic breeding pairs are 
(B6C3)F1 mice (C57BL/6J X C3H/FeB/J)F1, which maintain the op gene through breeding 
procedures involving the transplantation of ovaries from op/op mice into the (B6C3)F1 female 
(3). There are three genotypes that result in the offspring of these breeding pairs, which are F2 
mice. They are op/op, +/op, and  +/+  genotypically, and the latter two are phenotypically 
identical. We refer further to them as to the +/? mice. The mutant op/op mice are distinguished 
from the +/? mice by the absence of incisors and a characteristic skull deformation (3). The 
op/op mice used for these studies were 3-4 wk of age. The fact that young animals were used in 
these  studies should be  considered in the  interpretation of these  data,  as  should  the  poor 
nutritional status of these mice caused by their lack of incisors.  The diets of these mice were, 
however,  supplemented with a wet mesh chow. 
Culture Media.  RPMI 1640 (M. A. Bioproducts, Walkersville, MD) and Dulbecco's modified 
minimal essential media (DME, Flow Laboratories, Rockville, MD) were supplemented with 
L-glutamine (200 mM, Flow Laboratories), Hepes buffer (25 mM, Calbiochem-Behring Corp., 
Amerian Hoechst  Corp.,  San  Diego,  CA),  and  gentamycin (0.05  mg/ml,  Schering Corp., 
Kenilworth, N  J). When indicated, heat-inactivated fetal calf serum (FCS)  (Flow Laboratories; 
batch 29101224) and/or horse serum (HS)  (Flow Laboratories; batch 2911046) were used. 
Hematological Measurements.  Mice were bled by retroorbital puncture to obtain peripheral 
blood. The hematocrit and absolute leukocyte count were determined. Differential leukocyte 
counts were  performed on Wright's stained smears.  The peritoneal cavity of the  mice was 
lavaged with serum-free medium, the cells obtained were enumerated, and their differertial 
was determined from Wright's stained smears.  The cellularity of the spleen and thymus was 
determined from counts of single cell suspensions from these organs. The marrow cavity of the 
femurs was flushed out with serum-free media and the cells obtained were enumerated. 
Exogenous Spleen Colony-forming Unit (CFU-S) Assay  for Hemopoietic Stem Cells. The CFU-S assay 
was  performed  as  modified and described  previously (23). Cell  suspensions from  the  bone 
marrow, spleen, or liver from either individual test  animals or C57BL/6 mice were injected 
intravenously into groups of four lethally irradiated (750 rad) C57BL/6J recipients. Although 
the F2 donor cells were  injected into irradiated C57BL/6J mice, no differences between the 
syngeneic control and the experimental groups were detected suggesting that histocompatibility 
antigen differences  did not affect  the CFU-S measurement in this situation. 8 d after the cell 
transfer, the mice were killed, their spleens were removed and placed in Tellysniczky's  fixative. 
The surface colonies were then enumerated and examined histologically as described previously 
(23). 
Adherent Cell Cultures from Marrow and Spleen.  5  X  106 spleen or bone marrow cells  were 
cultured in 10 ml of DME supplemented with 10% FCS and 10% HS in 25-cm  2 tissue culture 
flasks (3013; Falcon Labware, Oxnard, CA) as previously described (24). The cells were cultured 
in triplicate in humidified air, 37°C, 5% CO2 for  14 d. The culture supernatants were removed 
and saved for later use as a source of marrow-adherent colony-conditioned  media (MACCM). 
The cells  in flasks  were  air dried,  stained with Wright's stain, and macroscopically visible 
colonies were  enumerated. Cultures were then evaluated microscopically. The colonies corn- 1518  OSTEOPETROSIS 
posed of both fibroblastoid cells and macrophages were apparent  as previously described (24). 
The  macrophages  observed to surround  individual  fibroblastoid  cells were enumerated.  Nor- 
really, colonies were made of fibroblastoid cells and were overgrown by macrophages that  also 
grew in intercolony spaces (24). 
In  ~5"tro  Monocyte-Macrophage Colony Formation.  The ability of spleen or marrow cells to form 
colonies of monocytes and macrophages was determined using an in vitro liquid cuhure system 
modified  from  Goud  et  al.  (25,  26)  and  described  earlier  (24).  Briefly, 0.5  to 5  X  105  spleen 
cells/ml or 5 X  104 bone marrow cells/ml were cultured  in 0.24 ml DME, supplemented  with 
20%  HS  and  20'~  MACCM  obtained  from  normal  C57BL/6J  bone  marrow-adherent  cell 
cultures  described  above.  This  MACCM  served  as  the source  of colony-stimulating activity 
(CSA). The cultures  in slide chambers  (Lab-Tek,  Naperville, IL)  were incubated  at  37°C  in 
humidified 5% CO2 atmosphere for 4 d. The culture supernatants  were then discarded, and the 
cells were  air-dried  and  stained  with  Wright's  stain.  The  colonies of >30  macrophages  and 
monocytes were scored and  had  similar cellular composition as those reported  by Goud et al. 
(25,  26), who used embryonal fibroblast conditioned medium as source of CSA. 
In  Vivo Stimulation oftYritoneal  Cells.  Mice were injected intraperitoneally with 0.5 ml of 3/7,: 
Brewers thioglycollate broth  (Difco Laboratories,  Detroit, MI).  5 d  later, the mice were killed 
and  the peritoneal  cells recovered by lavage were enumerated.  Subsequently,  differential cell 
counts were performed on Wright's stained smears. 
Reconstitution of Irradiated Mice.  (B6C3)F2-+/? recipient mice received 750 rad of X  irradiation 
24 h  before cell transfer.  5  X  106 spleen cells from  (B6C3)F2-op/op  or +/? mice were injected 
intravenously. The recipient mice were usually killed 10-15 d later, and the numbers of cells in 
the peripheral blood, spleen, femur, and peritoneal cavity were determined. 
In  Vivo Effects of MACCM.  Groups  of op/op  mice  daily  for  4  d  received  intraperitoneal 
injections of 0.5  ml of MACCM of normal  C57BL/6J  mice or unconditioned  DME supple- 
mented  with  10~7~ FCS  and  10%  HS.  On  day  7  mice were  killed and  number  of peritoneal 
lavage cells and their differential were determined. 
Irradiation of Mice.  Mice were irradiated  using a  bilateral X-ray source operated  at  a  dose 
rate of 120  rad/min  at  125  kV and  20  mA with 0.5-mm  Cu  filtration.  Irradiated  mice were 
housed  in laminar flow isolators and received sterile food, water, and bedding. 
Results 
Characterization  of Hematological  Status  of Osteopetrotric op/op Mice.  The  basic  hema- 
tological profile of op/op  mice and  their  normal  +/?  littermates  was  evaluated,  and 
the  data  obtained  are  summarized  in  Table  I.  The  animals  used  in  these  studies  as 
littermates  were age matched;  however,  osteopetrotic  mice always  weighed less than 
their normal  littermates.  The  direct  effect of the  nutritional  status  of the op/op  mice 
on their hematological profile is not known, but must be considered during evaluation 
of these  data.  The  results  of this  survey  demonstrated  no  differences  in  hematocrits 
and  absolute  granulocyte  counts  between op/op  and  normal  mice.  Leukocyte counts 
were  lower  in  osteopetrotic  animals,  owing  mainly  to  significant  lymphopenia.  The 
numbers  of cells obtained  from  the  femoral  marrow  cavities of op/op  mice were  10- 
fold  less  than  from  their  normal  littermates.  These  results  are  in  contrast  to  other 
murine  mutants  with  osteopetrosis,  in  which  there  is a  near complete obliteration  of 
marrow cavities (2). On cytological examination,  these marrow cells appeared  to have 
composition more typical of peripheral  blood than  of marrow.  They consisted of only 
4%  erythroblasts  and  6%  proliferating  granulocytes  (myeloblasts,  promyelocytes, 
myelocytes),  whereas  nonproliferating  granulocytes  (metamyelocytes,  stabs,  and  seg- 
ments)  accounted  for  47%  and  lymphocytes  for  38%  of the  total.  5%  of cells  were 
unclassifiable.  The organ cellularity of the spleen and  thymus of op/op and  littermate 
mice were essentially similar. In other osteopetrotic mutants  (1, 2) splenomegaly does WIKTOR-JEDRZEJCZAK, AHMED, SZCZYLIK,  AND  SKELLY 
TABLE  I 
Basic Hematological Parameters of Osteopetrotic (op/op) Mice and Normal 
Parameter 
(unit) 
Littermates * 
Mean ± SE 
(number of mice tested) 
+17 (5)  op/op (5) 
Weight (g)  11.8 + 0.5  6.02 + 0.45~: 
Hematocrit  (%)  46.1 --- 0.7  47.4 +  1.1 
Leukocyte count/#l blood  6600 +  700  3500 ± 900:~ 
Granulocyte count//.tl blood  1140 +-- 100  940 ± 200 
Lymphocyte count//.tl blood  5400 --. 800  2500 ±  700~ 
Cells/femur  ×  106  18.6 ± 0.8  1.8 ± 0.1§ 
Cells/spleen ×  106  70.6 + 5  43.8 ± 9.1:~ 
Cells/thymus ×  10  6  138.5 ±  12  177.5 ± 25 
Cells/ml of peritoneal  lavage  1.12 ± 0.07  0.13 ± 0.016§ 
x  10~[I 
* Mice were evaluated at 3-4 wk of age. 
:~ Difference significant (P < 0.05) when compared with normal littermates. 
§ Difference highly  significant  (P <  0.001)  when  compared with  normal 
littermates. 
]l Each mouse was lavaged with 5 ml of serum-free medium. 
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occur.  In  the  gray-lethal mice and  osteopetrotic  (op/op)  rat  models of osteopetrosis, 
thymic  atrophy  is  a  characteristic  feature  (2,  18).  The  normal  resident  peritoneal 
lavage  of op/op  mice  yielded significantly fewer  cells as  compared  with  littermate 
mice, and this difference was further analyzed. 
Differentiation of Macrophages in Osteopetrotic and Littermate Mice.  Comparison of the 
indices of various stages of macrophage-poiesis in  osteopetrotic and  normal  mice  is 
shown in Table II. The organ distribution of hemopoietic stem cells in op/op mice was 
altered. The CFU-S concentration in op/op marrow was considerably smaller than in 
normal  marrow,  which  must  also be considered in  view of the overall reduction  in 
marrow cellularity in these mice (Table I). On the other hand,  spleen had increased 
concentration  of these  cells,  and  unlike  normal  mice  of this  age,  op/op  mice  had 
considerable  numbers  of  stem  cells  present  in  the  liver.  However,  the  size  and 
differentiation pattern  of spleen  colonies  formed  by op/op  cells did  not  differ  from 
similar  parameters  for  normal  cells  (data  not  shown).  In  view  of the  scarcity  of 
peritoneal lavage cells in op/op mice, the unexpected result was the demonstration of 
very  good  growth  of  macrophage  colonies  from  osteopetrotic  spleen  cells  in  the 
presence of MACCM.  Not only was the formation of these colonies better (15 times) 
than  in the case of normal spleen cells, but  it was also better than  the formation of 
these colonies by normal littermate marrow  (97 +  12 colonies/105 marrow cells). The 
photographs of these colonies are shown in Fig.  1. These data also contrast with other 
observations;  i.e.,  very  low  absolute  monocyte  count  in  the  peripheral  blood  and 
extremely low macrophage count  per ml of peritoneal lavage. On the other hand,  it 
must be mentioned that is was possible to distinguish individual macrophage-like cells 
in peritoneal lavage ofop/op mice. Nevertheless, these studies demonstrated that under 
appropriate conditions, progenitor cells from op/op mice are capable of differentiating 
in vitro into macrophages, although they largely fail to do so in vivo in op/op  mice. 
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TABLE  II 
Comparison of Various Stages of Macrophage-Poiesis in Osteopetrotic and Littermate Mice * 
Mean +  SE 
Stage of  (number of mice tested) 
differentiation  Index 
tested  +/?  (7)  op/op (5) 
Hemopoietic stem cell  Exogenous spleen colony 
formation: 
by marrow/105 cells  27.1  +  2.2  6.8 +  1.3:~ 
by spleen/10  ~ cells  57.6  +  5.3  88.7  --  1.8:~ 
by liver/10  ~ cells  None  12.1 +  3.2:~ 
Monoblast  Monocyte-macrophage  18.7 +  5.1  270.3  +  15:~ 
colony formation by 
spleen/10  s cells 
Monocyte  Monocytes/~l of  730 --- 60  29 +  10:~ 
peripheral blood 
Macrophage  Macrophages/ml of  4.2 ___ 0.4  0.085 +  0.01:~ 
peritoneal  lavage  × 
10t§ 
* Mice were evaluated at 3  4 wk of age. 
Difference highly significant (P <  0.001)  when compared with normal littermates. 
§ Each mouse was lavaged with 5 ml of serum-free medium. 
FIo.  1.  Formation of macrophages in vitro in the presence of CSA from MACCM  in 4-d liquid 
cultures:  (a)  macrophage colonies formed by  normal  +/?  spleen  cells;  (b)  macrophage  colonies 
formed by equal numbers ofop/op spleen cells. Wright's stain, 200 X. 
Osteopetrotic  and Normal Mice.  Both  marrow  and  spleen  cells  from  op/op  mice  formed 
lower  numbers  of adherent  macroscopic  colonies  (Table  III)  than  similar  cells  from 
their  normal  littermates.  Moreover,  cellular  composition  of these  colonies was  essen- 
tially altered  in op/op  marrow  and  spleen cultures.  Both  marrow  and  spleen cells from 
op/op  mice  formed  almost  pure  colonies  of  fibroblastoid  cells  and  the  number  of WIKTOR-JEDRZEJCZAK, AHMED, SZCZYLIK,  AND SKELLY 
TABLE III 
The Formation of Adherent Cell Colonies by Cells  from Hemopoietic Organs of 
Osteopetrotic and Littermate Mice * 
1521 
Mean (+ SD) 
C,  enotype of cell  Mean (+ SD) num-  number of macro- 
Origin of tested  donor (number of  ber of macroscopic  phages per fibrob- 
cells  mice tested)  colonies/106 cells  lastoid cell in these 
colonies:]: 
Marrow  +/?  (4)  12.1 ±  1.1  13.3 _  5 
op/op  (4)  1.8 ± 0.3§  1.15 :t: 1.4§ 
Spleen  +/?  (6)  7.2 +  1.3  9.6 ±  4.1 
op/op  (6)  5.7 ±  1.3  2.8 -  1.9§ 
* Mice evaluated at 3-4 wk of age. 
:~ Based on evaluation of between 50 and 100 individual fibroblastoid cells. 
§ Significance level P <  0.001 when compared with normal littermates. 
macrophages  in  these  colonies  was  very  low,  equal  to  approximately one  per  one 
fibroblastoid cell (Table III, Fig. 2).  In normal mice, macrophages were much  more 
numerous than fibroblastoid cells, were overgrowing colonies formed by fibroblastoid 
cells, and  frequently  formed  monolayer between  colonies of fibroblastoid cells. Al- 
though in cultures of cells from op/op mice macrophages were also scattered between 
colonies, their frequency was  very low.  An  index was  established to  quantitate  this 
decrease in the number of macrophages, and this index reflects the mean number of 
macrophages attached to the individual fibroblastoid cell. As seen in Table III, there 
was an  ~ 10-fotd decrease in the number  of macrophages attached to the individual 
fibroblastoid cell in cultures of op/op  cells, the difference being more pronounced  in 
the case of marrow cultures than in the case of spleen cultures. 
Attempts to Transfer the Macrophage Defect of the op/op Mouse into Normal Mice with Spleen 
Cells.  Osteopetrotic op/op  mice are among  those mutants  whose  response to hemo- 
poietic transplants is unknown;  similarly, the transferability of the defect with spleen 
cells was untested. Therefore, the ability of spleen cells from op/op mice to transfer the 
macrophage  defect  into  irradiated  (750  rad)  (B6C3)Fz-+/?  mice  was  investigated 
(Table  IV).  Only one  mouse,  which  did not  receive any  transplant,  survived  15  d, 
and the results of the evaluation of this mouse are shown  as reference. Values of all 
tested  parameters  in  recipients  of both  op/op  and  +/?  spleen  cells were  obviously 
different from the values for the unreconstituted mouse. Moreover, recipients of op/op 
spleen cells by all indices were reconstituted better than recipients of +/? spleen cells. 
Particularly, the  number  of macrophages  in  peritoneal cavity of recipients of op/op 
spleen cells was twice this number in recipients of+/?  spleen cells. Similar observations 
were made for mice studied 11 and  13 d  postirradiation (data not shown). There were 
also two recipients of op/op  spleen cells that  survived 4  wk after transplant.  Both of 
them showed full reconstitution including normal number of cells and normal number 
of macrophages per ml of peritoneal lavage (data not shown). Unfortunately, none of 
the  recipients of +/?  spleen  cells survived  that  long.  On  no  occasion were  signs of 
graft-vs.-host disease observed in recipient animals. Therefore, it appeared that op/op 
spleen  cells  possessed  increased  reconstitution  potential,  in  agreement  with  their 
increased  content  of  stem  cells.  This  observation  also  concerned  the  number  of FIG.  2.  Adherent colonies formed by normal +/?  and op/0p  marrow cells:  (a)  low-power  (15 ×) 
photograph of representative colonies formed in  14-d liquid culture of +/? marrow;  (b)  [ow-pnwer 
(15 X)  photograph  of  representative  adherent  colonies  formed  in  14-d  liquid  culture  of 0p/0p 
marrow; (c) representative fibroblastnid ceils with attached macrophages on peripheries of adherent 
colony formed by +/?  marrow:  (d)  representative fibroblastnid cells with  individual macrophagcs 
on peripheries of adherent colony formed by op/op marrow. ~Vright's stain, c and d:  magnification 
250 x. 
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TABLE  IV 
Postirradiation Reconstitution of (B6C3)F2 +/? Mice with Spleen Cells of 
Osteopetrotic and Littermate Mice * 
1523 
Parameter of reconstitution 
Genotype of spleen cell donor: mean + SD 
(number of mice tested) 
None (1)  +/? (5)  op/op (7) 
Leukocyte count//.d  0.2  0.8 + 0.3  1.2 + 0.25~: 
Cells/spleen X 10  6  3.0  35 +  10  56 +  12§ 
Cells/femur  ×  10  6  0.7  2.6 +-- 0.6  3.6 +-- 0.5:~ 
Cells/ml of peritoneal lavage  0.24  0.5 + 0.1  0.7 + 0.15:~ 
X 10  ~ 
Macrophages/ml of peritoneal  0.1  0.2 + 0.05  0.4 + 0.06[] 
lavage ×  106 
* Recipient  mice were irradiated with  750 rad of X rays 24 h before reconstitution 
and evaluated  15 d after transfer of 5 ×  10  6 spleen cells. 
:~ Significance level is P < 0.05 when compared with recipients of +/? spleen cells. 
§ Significance level is P < 0.01 when compared with recipients of +/? spleen cells. 
]] Significance level is P < 0.001 when compared with recipients of +/? spleen cells. 
macrophages  in  peritoneal  lavage.  Consequently,  the  macrophage  defect  in  op/op 
mice appeared to be nontransplantable with op/op spleen cells. 
Discussion 
The hematological characterization of the op/op mouse revealed that these animals 
are deficient in their monocyte and macrophage populations. These mice possess few 
monocytes  in  the peripheral blood and  few  macrophages  in  their peritoneal cavity. 
However,  the  progenitor cells for  macrophages  and  monocytes  are present  in  these 
mice,  as  was  demonstrated  by  the  in  vitro  growth  of macrophage  colonies  in  the 
presence of CSA from media conditioned by adherent cells from the bone marrow of 
normal mice. Bone marrow and spleen cells from op/op mice did form  adherent  cell 
colonies when  cultured in vitro; however, these colonies, when  compared with those 
from  normal  littermate  mice,  were  composed  primarily of fibroblastoid cells, with 
extremely few macrophages. The macrophage defect in these op/op mice could not be 
transplanted  into  irradiated mice  by op/op mouse  spleen cells. In  addition to  these 
macrophage-related deficiencies, the op/op mice showed an altered organ distribution 
of hemopoietic stem cells with an increased number of these cells being found in the 
spleen  and  liver.  Furthermore,  these  op/op  mice  were  lymphopenic,  yet  possessed 
normal thymus cellularity. 
These results strongly suggest that a  primary lesion in this particular animal model 
of osteopetrosis results in the inability of the monocyte-macrophage cell line to fully 
differentiate. Previous characterization of this osteopetrotic mutant  has  revealed an 
absence of functional  osteoclasts, the  primary cells involved in  bone  resorption  (3). 
The relationship between macrophages and osteoclasts has been strengthened by the 
observation  that,  in  vitro,  macrophages  are  capable  of effecting  osteoclast-like re- 
sponses to bone resorption stimuli (27, 28).  Specifically, the osteopetrosis in the op/op 
mouse  would  result  from  a  defect  in  the  ability  of stromal  fibroblastoid  cells  to 
produce  monocyte-macrophage  CSA,  resulting  in  increased  numbers  of monocyte- 
macrophage  progenitor  cells and  few  mature  cells.  The  lack of these  mature  cells 1524  OSTEOPETROSIS 
would preclude their fusion to form osteoclasts. Therefore, the clinical manifestations 
of osteopetrosis, resulting from the absence of osteoclasts, are proposed to be the result 
of the inability of the fibroblastoid cells to promote the maturation  of monoblasts to 
monocytes, macrophages, and osteoclasts presumably because of a lack of production 
of  functional  CSA.  CSA  are  a  series  of  glycoproteins  that  display  considerable 
structural and antigenic heterogeneity, depending on the tissue of origin (29), yet are 
highly  specific  with  regard  to  their  capacity  to  stimulate  only  macrophage  or 
granulocyte maturation  (29,  30)  from progenitor cells.  In the in vitro system used in 
these studies, the targets of the CSA were already committed cells for macrophage or 
granulocyte differentiation  (25, 26), and it was possible that different CSA glycopro- 
teins were present  and responsible for the stimulation  of maturation  of each of these 
cell  types.  In  the op/op mouse,  for example,  normal  numbers  of granulocytes  were 
present.  However,  macrophage  maturation  proceeded  only to the  monoblast  stage, 
suggesting that  the op/op mouse does not  completely lack all  types of CSA.  On  the 
other hand, it is possible that an epitope of these glycoproteins is required for the full 
differentiation  of each cell lineage and that one of these is absent  in op/op mice.  It is 
thus possible that it is merely a  reflection of a  quantitative  or structural  defect in the 
glycoprotein essential  for this cell lineage.  The purification  and biochemical charac- 
terization  of CSA  glycoproteins  will  aid  in  the  study  of the  different  stimuli  for 
macrophage differentiation. 
Our data do suggest that the absence of macrophages in the 0p/0p mice results from 
the absence of a biochemical signal for differentiation rather than from a deviation in 
differentiation.  Hemopoietic cells  from op/op mice can be stimulated  to differentiate 
into macrophages in vitro when provided with a CSA from normal mice. Furthermore, 
while  the  injection  of a  nonspecific stimulant  such as thioglycollate failed to induce 
the appearance of macrophages in vivo, the injection of MACCM  as a source of CSA 
from normal mice into op/op mice resulted in the marked appearance of macrophages 
in the op/op mouse peritoneal  exudates  (unpublished  observations). 
The lack of the appropriate  source of macrophage CSA in op/op mice rather than 
an  abnormal  monoblast  was  also  suggested  by  the  morphological  appearance  of 
fibroblastoid cell colonies from marrow and spleen of op/op mice.  Fibroblastoid  cells 
that  form  adherent  cell  colonies  in  liquid  cultures  of bone  marrow  cells  are  the 
precursor cells of bone stromal  tissue  (20,  31, 32).  In vivo, the bone stromal  tissue  is 
one of the best sources of CSA (29, 33, 34). In cultures of marrow or spleen cells from 
normal mice, macrophages adhere directly to fibroblastoid cells. In contrast, the bone 
marrow cells  cultured  from op/op mice  formed  fibroblastoid  cell  colonies,  yet  these 
op/op cells did not support  the attachment  of the few macrophages that were present 
in these cultures to the fibroblastoid cells. 
The  macrophage  defect  of op/op mice  could  not  be  transferred  into  irradiated 
normal mice by spleen cells. This observation contrasts the osteopetrosis of both mi/mi 
and gl/gl mice mutants that are transferable  by spleen cells  (8,  9). The nontransfera- 
bility  of the  op/op mouse  disease  supports  an  environmental  defect  rather  than  a 
defect intrinsic to cells of hemopoietic lineage. A similar situation  may exist in the tl/ 
tl rat model of osteopetrosis, which is resistant  to cure by hemopoietic cells  (19). This 
rat  mutant  is  also  similar  to  the  op/op mouse  in  that  the  tl/tl  rat  possesses  few 
macrophages and monocytes (W. Wiktor-Jedrzejczak, unpublished observation). 
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their ability to stimulate macrophage differentiation by the production of a functional 
CSA is limited by the fact that other cells, such as lymphocytes (35) and macrophages 
(36)  also  produce  CSA.  However,  the  CSA  produced  by  these  cells  may  not  be 
synthesized and/or functional in the assay systems used in our studies. The ultimate 
proof of the absence of an active macrophage CSA awaits the purification of CSA. 
The abnormal  distribution  of stem cells and  lymphopenia observed in  the op/op 
mice  are  most  probably  secondary  manifestations  of osteopetrosis  caused  by  the 
absence of a  functional  marrow environment.  Indeed,  in  support  of this,  a  similar 
abnormal distribution  of stem cells was observed in estrone-induced osteopetrosis of 
mice (37).  Similarly, the effects of a poor nutritional status, caused by the absence of 
incisors in these mice, cannot be disregarded, although earlier studies (2) of all murine 
osteopetrotic  mutants  failed  to  identify  any  common  abnormalities  that  could  be 
related to starvation of these mice. 
In summary, our studies demonstrated a profound absence of mature macrophages 
in  the  op/op mice.  Because  these  op/op mice  do  possess  the  progenitor  cells  for 
monocytes  and  macrophages,  the  defect  appears  to  result  from  the  absence  of 
appropriate stimuli or environment for differentiation.  The disease was nontransfer- 
able into irradiated mice, further indicating that the lesion resulting in osteopetrosis 
in  op/op mice was  environmental  rather  than  caused  by an  abnormal  stem cell  or 
progenitor cell. The osteopetrosis of the op/op mice is similar to that observed in tl/tl 
rat  (unpublished  observations), in contrast  to the lesions leading to osteopetrosis in 
gl/gl and mi/mi mice and op/op and ia/ia rats. The osteopetroses in these latter models 
are  transferable  by  hemopoietic  cells  and  corrected  by  transplantation  of normal 
hemopoietic  cells.  Furthermore,  our  data  strongly  suggest  that  the  environmental 
lesion  in  the  op/op mouse  resides  in  the  inability  of  their  hemopoietic  stromal 
fibroblastoid  cells  to  produce  monocyte-macrophage  CSA.  The  lesion  has  been 
demonstrated  to  be  the  result  of  a  single  autosomal  recessive  gene  located  on 
chromosome 3  (38).  Therefore, this mutant may be useful for the studies of differen- 
tiation and functional role of macrophages. 
Summary 
Compared with normal littermates, the op/op mice had very few macrophages in 
the peritoneal cavity and severely reduced  numbers of monocytes in  the peripheral 
blood. Moreover, osteopetrotic animals demonstrated an altered distribution of hem- 
opoietic tissue with  a  10-fold decrease in  the number of marrow cells.  Liver hemo- 
poiesis persisted in 4-wk-old mice as evidenced by the presence of hemopoietic stem 
cells  (HSC).  Moreover,  the  concentration  of HSC  was  decreased  in  marrow  and 
increased  in  the spleen  of op/op mice.  In spite of the  paucity of cells of monocyte- 
macrophage lineage in  vivo, progenitor cells from hemopoietic tissues of op/op mice 
formed increased numbers of monocyte-macrophage colonies in vitro in the presence 
of exogenous colony-stimulating activity (CSA). The source of this critical CSA was 
a  medium conditioned  by stromal  fibroblastoid colonies formed in vitro by normal 
marrow cells. Therefore, these data suggest that op/op mice possess normal monocyte- 
macrophage-osteoclast progenitor cells but these cells are unable to fully differentiate 
in  the  op/op mouse  microenvironment.  In  support  of this,  in  cultures  of stromal 
fibroblastoid  colonies  from  op/op marrow  or  spleen,  the  concomitant  growth  of 
macrophages, normally very dense,  was drastically reduced.  Moreover, transplanta- 1526  OSTEOPETROSIS 
tion of op/op spleen cells into lethally irradiated littermate recipients resulted in their 
hemopoietic  reconstitution  without  signs  of  macrophage  defect.  Thus,  the  op/op 
splenic cells do not transfer the disease and are capable of normal differentiation in 
normal  in  vivo  environment. These  observations support  the  hypothesis  that  the 
defect in op/op mice is a result of the failure of hemopoietic stromal fibroblastoid cells 
to  release sufficient amounts of CSA necessary for normal differentiation of cells of 
the monocyte-macrophage lineage. 
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